Hennessy Capital Investment Corp. VII
NASDAQ:HVIIFinancial - Conglomerates
-$0.01 today
- Market cap
- $116.06M
- Beta
- 0.05
- P/E (TTM)
- 61.2
- EPS (TTM)
- $0.17
Volume 10.51M
Average 0.05M
HVII Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Hennessy Capital Investment Corp. VIINASDAQ: HVII
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin grows 124.3% year over year
Q1 FY2026 selling, general & admin of $1.1M rose 124.3% year over year. Sequentially, it fell 42.2% from the prior quarter.
What to watch
Whether selling, general & admin reaches the consensus estimate of $0 (-100.0%) for the fiscal year ending Dec 2026, a slowdown from the +7525.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $1.1M-42.2% QoQ
- Last fiscal yearDec 2025
- $3.66M+7525.5% YoY
- LTMMar 2026
- $4.26M— YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +124.3% | -100.0% | -224.3 pp |
| 1 year | +7525.5% | -100.0% | -7625.5 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 3.66M USD
- Year-over-year change
- +7525.5%
- 1-year CAGR
- +7525.5%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.66M | +7525.5% |
| FY2024 | 2024-12-31 | 47.95K | — |
Selling, General & Admin vs competitors
How HVII compares with its peers on the latest reported figures
- HVII's LTM Mar 2026 selling, general & admin of $4.26M is the 2nd highest of the 11 companies compared; the peer median is $1.37M.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
DRDBRoman DBDR Acquisition Corp. II | LTM Mar 2026 | $5.05M | — | — | — |
| LTM Mar 2026 | $4.26M | — | — | — | |
AACBArtius II Acquisition Inc. Class A Ordinary Shares | LTM Mar 2026 | $3.62M | — | — | — |
| LTM Mar 2026 | $2.38M | -72.8% | — | — | |
| LTM Mar 2026 | $2.18M | — | — | — | |
POLEAndretti Acquisition Corp. II | LTM Mar 2026 | $1.53M | +207.9% | — | — |
OACCOaktree Acquisition Corp. III Life Sciences | LTM Mar 2026 | $1.21M | — | — | — |
| LTM Mar 2026 | $967.64K | +175.5% | — | — | |
| LTM Mar 2026 | $934.55K | +96.3% | — | — | |
| FY2025 | $185.83K | — | — | — | |
BEAGBold Eagle Acquisition Corp. | LTM Mar 2026 | -$268.13K | -151.5% | — | — |
| Peer median (excluding HVII) | $1.37M | +96.3% | — | — | |
Competitors are the stored peer set for HVII. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | 0 | 0 |
| Gross Profit | 0 | 0 |
| Gross Margin | — | — |
| Research & Development | 0 | 0 |
| Selling, General & Admin | 47.95K | 3.66M |
| Operating Expenses | 47.95K | 3.66M |
| Depreciation & Amortization | 0 | 0 |
| EBITDA | (47.95K) | (3.66M) |
| EBITDA Margin | — | — |
| Operating Income | (47.95K) | (3.66M) |
| Operating Margin | — | — |
| Interest Income | 0 | 7.34M |
| Interest Expense | 0 | 0 |
| Other Income / Expenses | 0 | 7.34M |
| Income Before Tax | (47.95K) | 3.69M |
| Pre-Tax Margin | — | — |
| Income Tax Expense | 0 | 0 |
| Net Income | (47.95K) | 3.69M |
| Net Margin | — | — |
| EPS (Basic) | (0.00) | 0.15 |
| EPS (Diluted) | (0.00) | 0.15 |
| Weighted Avg Shares | 26.02M | 17.91M |
| Weighted Avg Shares (Diluted) | 26.02M | 17.91M |
Hennessy Capital Investment Corp. VII
NASDAQ:HVII
Intrinsic Alpha fair value
Locked
Current Price
$4.46
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.